American Stock Exchange Accepts Proterion's Plan to Regain Compliance with Continued Listing Standards.Business Editors/High-Tech Writers PISCATAWAY, N.J.--(BUSINESS WIRE)--Aug. 21, 2003 Proterion Corporation (AMEX AMEX See: American Stock Exchange :PRC), a leading provider of computer-controlled life sciences instrumentation for particle sizing and biomolecular characterization of protein molecules, announced today that the American Stock Exchange American Stock Exchange (AMEX) Stock exchange in the U.S. Originally known as “the Curb,” it began as an outdoor marketplace in New York City c. 1850. It moved indoors to its present location in the Wall Street area in 1921. has accepted the Company's plan to regain compliance with the continued listing standards. On May 23, 2003, the Company received notice from the Staff of the American Stock Exchange indicating that the Company is below certain of the Exchange's continued listing standards as set forth in Section 1003(a)(ii) of the Amex Company Guide which provides that the Exchange may consider suspending dealings in, or delist delist To drop a security from trading on an organized exchange. Delisting may occur for a number of reasons including failure to meet an exchange's standards or placement of a new listing on another exchange. Compare list. , securities of a company which has stockholders' equity Stockholders' Equity The portion of the balance sheet that includes capital received from investors in exchange for stock (paid-in capital), donated capital, and retained earnings. This is equal to total assets minus liabilities, preferred stock and intangible assets. of less than $4,000,000 if such company has sustained losses from continuing operations continuing operations Parts of a business that are expected to be maintained as an ongoing segment of an overall business operation. Income and losses from continuing operations are reported separately if any segments have been discontinued during the and/or net losses in its last three of its four most recent fiscal years. On July 7, 2003, the Company submitted a plan of compliance to the Exchange and on August 13, 2003 the Exchange notified the Company that it accepted the Company's plan of compliance and granted the Company an extension of time until November 23, 2004 to regain compliance with the continued listing standards. The Company will be subject to periodic review by Exchange Staff during the extension period. Failure to make progress consistent with the plan or to regain compliance with the listing standards by the end of the extension period could result in the Company being delisted from the American Stock Exchange. About Proterion Corporation Proterion Corporation designs, manufactures, markets, and services computer-controlled life sciences instrumentation for particle sizing and biomolecular characterization of protein molecules. The Company has a "Plasmon Waveguide waveguide, device that controls the propagation of an electromagnetic wave so that the wave is forced to follow a path defined by the physical structure of the guide. Resonance" spectrometer spectrometer Device for detecting and analyzing wavelengths of electromagnetic radiation, commonly used for molecular spectroscopy; more broadly, any of various instruments in which an emission (as of electromagnetic radiation or particles) is spread out according to some under development, which provides important information not previously attainable with a traditional SPR spr Spring SPR Strategic Petroleum Reserve SPR Surface Plasmon Resonance SPR Suomen Punainen Risti SpR Specialist Registrar (UK doctor who supports a consultant) SPR Society for Psychical Research SPR Stop Prisoner Rape type spectrometer. The Company's other established products, most of which are proprietary or patented, consist of spectrometers and light scattering laboratory instruments, which are also used for research, biological product development, and drug candidate selection. These instruments combine special sampling technologies and multiple sensor technologies to provide various measurements. Pharmaceutical, biotechnology, and Government-funded research and development laboratories use the products to understand the physical attributes of purified protein molecules. The Company markets its products globally under the "Aviv" and "Protein Solutions" trademarks. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion